Source Genomics Expands Sequencing Portfolio with First UK Commercial Service on the Element Biosciences AVITI™ System
Source Genomics Expands Sequencing Portfolio with First UK Commercial Service on the Element Biosciences AVITI™ System
Cambridge, UK, 31 January 2024: Source Genomics, a part of the Source BioScience Group, today announced their genomic laboratory expansion by adding an Element Biosciences AVITI™ System to its fleet of sequencers.
As the demand for genomic sequencing increases in the UK, Source Genomics is expanding its offering to meet the escalating needs of the life science research market. The incorporation of Element Biosciences AVITI™ System is set to transform the landscape of genomic sequencing with unprecedented accuracy and cost, allowing researchers additional flexibility for accelerated discovery with next-generation sequencing. This strategic enhancement will position Source Genomics at the forefront of genomic research capabilities and will provide a new tier of support for its projects and partners moving forward.
Source Genomics is an established laboratory service partner with a vast portfolio of genomic and multi-omic services, helping biopharmaceutical companies and academic organisations accelerate their research and development programmes. With the expanded offering, Source Genomics is better positioned to support customers with a variety of technologies depending on their requirements, whilst maintaining its renowned high-quality services.
Richard Stevens, Director of Genomics, commented:
“The expansion of our laboratory fleet signals a significant step forward in enabling Source Genomics to spearhead the newest advancements in the field of genomic sequencing. The addition of the Element Biosciences AVITI™ System serves as a testament to our commitment to staying at the forefront of genomic innovation and will allow us to support the field of genomic research with enhanced flexibility. Given the role genetic analysis plays in many facets of research, we are pleased to further develop our portfolio to integrate the most cost-effective, high-quality sequencing options for our customers.”
About Source BioScience Ltd www.sourcebioscience.com
Source Genomics, a part of the Source BioScience Group, provides a multi-omics approach for high quality data delivery in Genomics, Epigenomics, Spatial Transcriptomics and Proteomics. Market leaders for Sanger Sequencing and Next-Generation Sequencing services including Nanopore Sequencing, Whole Genome Sequencing, Metagenomics and more, Source Genomics is your trusted laboratory service partner for your project, with unrivalled turnaround times.
About Element Biosciences
Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing and other omics technology for research markets. Through innovating every fundamental element of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic research. To learn more about Element, please visit www.elementbiosciences.com.
